Molecular alterations monitoring in myelodysplastic patients receiving an allogeneic hematopoietic stem cell transplantation after a reduced-intensity conditioning regimen

被引：0

作者：

Robin, Marie ^{[1
]}

Nibourel, Olivier ^{[2
]}

Tournaire, Martin ^{[3
]}

Michonneau, David ^{[1
]}

Preudhomme, Claude ^{[2
]}

Verbanck, Marie ^{[3
]}

Xhaard, Alienor ^{[1
]}

Ades, Lionel ^{[4
]}

de Fontbrune, Flore Sicre ^{[1
]}

Sebert, Marie ^{[4
]}

Fenaux, Pierre ^{[4
]}

Socie, Gerard ^{[1
]}

de Latour, Regis Peffault ^{[1
]}

Curis, Emmanuel ^{[3
,5
]}

机构：

[1] Univ Paris Cite, Hop St Louis, Hematol Greffe, Paris, France

[2] Univ Lille, CHU Lille, CANTHER Canc Heterogene Plast & Resistance Therapi, CNRS,Inserm,UMR9020,U1277, F-59000 Lille, France

[3] Univ Paris Cite, Fac Pharm Paris, UR 7537, BioSTM, 4 Ave Observ, F-75014 Paris, France

[4] Univ Paris, Hop St Louis, Hematol, Paris, France

[5] Hop Lariboisiere, AP HP, Lab Hematol, 2 Rue Ambroise Pare, F-75010 Paris, France

来源：

BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 09期

关键词：

DONOR AVAILABILITY; RESIDUAL DISEASE; LEUKEMIA;

D O I：

10.1038/s41409-024-02314-2

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1309 / 1312

页数：4

共 50 条

[1] Allogeneic haemopoietic stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome
Rudnitskaya, Y. V.
Morozova, E.
Zalyalov, Yu.
Kazantsev, I.
Afanasyev, B.
BONE MARROW TRANSPLANTATION, 2010, 45 : S406 - S407
[2] Nephrotic syndrome after allogeneic transplantation of haematopoietic stem cell with a reduced-intensity conditioning regimen
Benakli, M.
Ahmed-Nacer, R.
Talbi, A.
Mehdid, F.
Belhadj, R.
Rahmoune, N.
Hamladji, R. M.
BONE MARROW TRANSPLANTATION, 2007, 39 : S279 - S279
[3] Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen
A Poloni
P Leoni
L Buscemi
F Balducci
R Pasquini
M C Masia
N Viola
E Costantino
G Discepoli
P Corradini
A Tagliabracci
A Olivieri
Leukemia, 2006, 20 : 329 - 335
[4] Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen
Poloni, A
Leoni, P
Buscemi, L
Balducci, F
Pasquini, R
Masia, MC
Viola, N
Costantino, E
Discepoli, G
Corradini, P
Tagliabracci, A
Olivieri, A
LEUKEMIA, 2006, 20 (02) : 329 - 335
[5] Immunomodulation in patients with solid tumour progressing after allogeneic stem cell transplantation and reduced-intensity conditioning regimen
Sarina, B
Mazza, R
Castagna, L
Todisco, E
Bertani, G
Timofeeva, I
BONE MARROW TRANSPLANTATION, 2005, 35 : S203 - S203
[6] Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
Haefaa Alchalby
Nicolaus Kröger
Current Hematologic Malignancy Reports, 2010, 5 : 53 - 61
[7] Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
Alchalby, Haefaa
Kroeger, Nicolaus
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (02) : 53 - 61
[8] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
Nihtinen, A
Volin, L
Juvonen, E
Ruutu, T
BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
[9] A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation
Nelson, Adam S.
Marsh, Rebecca A.
Myers, Kasiani C.
Davies, Stella M.
Jodele, Sonata
O'Brien, Tracey A.
Mehta, Parinda A.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) : 884 - 888
[10] REDUCED-INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Kuzmina, Larisa A.
Parovichnikova, Elena N.
Sorokina, Tamara V.
Petinati, Natalia A.
Drokov, Michail Y.
Savchenko, Valeriy G.
ANNALS OF HEMATOLOGY, 2013, 92 : S18 - S19

← 1 2 3 4 5 →